Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bielack

Showing results (161-170 of 184) with videos related to

Pageof 19
Sort By:
Cancer Medicine|January 18, 2019
Desmoplastic small round cell tumors: Multimodality treatment and new risk factorsMonika Scheer, Christian Vokuhl, Bernd Blank, et al.
Journal of Cancer Research and Clinical Oncology|January 15, 2020
Synovial sarcoma disease characteristics and primary tumor sites differ between patient age groups: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS)Monika Scheer, Bernd Blank, Sebastian Bauer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2017
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patientsA Longhi, S S Bielack, R Grimer, et al.
European Journal of Cancer Care|August 5, 2015
Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated projectD Stark, S Bielack, L Brugieres, et al.
Tumori|December 9, 2017
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcomaStefano Ferrari, Stefan S Bielack, Sigbjørn Smeland, et al.
BMC Cancer|January 8, 2020
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature reviewJ Salchow, J Mann, B Koch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2014
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatmentJ S Whelan, S S Bielack, N Marina, et al.
Clinical Sarcoma Research|June 18, 2016
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop ReportLeo Kager, Jeremy Whelan, Uta Dirksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialStefan S Bielack, Sigbjørn Smeland, Jeremy S Whelan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2019
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Stefan S Bielack, Jeremy Whelan, et al.
Pageof 19

Showing results (161-170 of 184) with videos related to

Sort By:
Pageof 19
Cancer Medicine|January 18, 2019
Desmoplastic small round cell tumors: Multimodality treatment and new risk factorsMonika Scheer, Christian Vokuhl, Bernd Blank, et al.
Journal of Cancer Research and Clinical Oncology|January 15, 2020
Synovial sarcoma disease characteristics and primary tumor sites differ between patient age groups: a report of the Cooperative Weichteilsarkom Studiengruppe (CWS)Monika Scheer, Bernd Blank, Sebastian Bauer, et al.
European Journal of Cancer (Oxford, England : 1990)|February 8, 2017
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patientsA Longhi, S S Bielack, R Grimer, et al.
European Journal of Cancer Care|August 5, 2015
Teenagers and young adults with cancer in Europe: from national programmes to a European integrated coordinated projectD Stark, S Bielack, L Brugieres, et al.
Tumori|December 9, 2017
EURO-B.O.S.S.: A European study on chemotherapy in bone-sarcoma patients aged over 40: Outcome in primary high-grade osteosarcomaStefano Ferrari, Stefan S Bielack, Sigbjørn Smeland, et al.
BMC Cancer|January 8, 2020
Comprehensive assessments and related interventions to enhance the long-term outcomes of child, adolescent and young adult cancer survivors - presentation of the CARE for CAYA-Program study protocol and associated literature reviewJ Salchow, J Mann, B Koch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 26, 2014
EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatmentJ S Whelan, S S Bielack, N Marina, et al.
Clinical Sarcoma Research|June 18, 2016
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop ReportLeo Kager, Jeremy Whelan, Uta Dirksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2015
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled TrialStefan S Bielack, Sigbjørn Smeland, Jeremy S Whelan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 28, 2019
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohortSigbjørn Smeland, Stefan S Bielack, Jeremy Whelan, et al.
Pageof 19